Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE-EB: Curcumin PDT for Oral Lesions in Epidermolysis Bullosa
NCT07596927Phase 4Active, not recruiting
- Sponsor
- Universidade Ceuma
- Start
- Jan 2026
- Primary completion
- Jan 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of curcumin in epidermolysis bullosa (EB), sponsored by Universidade Ceuma. Started Jan 2026; status: active, not recruiting.
02
Drugs
curcumin
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT07596927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596927.